Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Back to Technology
Technology
October 14, 2026 at 11:00 PM
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
TechCrunch
Excerpt from TechCrunch.